These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 18927967

  • 1. [First results of clinical studies on botulinum toxin A in migraine and headache].
    Tiesler U.
    Nervenarzt; 2008 Jun; 79 Suppl 1():44-6. PubMed ID: 18927967
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT.
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [Abstract] [Full Text] [Related]

  • 3. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group.
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M, Silva S, Cottrell C.
    Headache; 2008 Sep; 48(10):1476-81. PubMed ID: 19076646
    [Abstract] [Full Text] [Related]

  • 6. Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients.
    Schim J.
    Curr Med Res Opin; 2004 Jan; 20(1):49-53. PubMed ID: 14741072
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA, Buwalda J.
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [Abstract] [Full Text] [Related]

  • 9. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Dodick D, Blumenfeld A, Silberstein SD.
    Clin Dermatol; 2004 Apr; 22(1):76-81. PubMed ID: 15158549
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A in chronic migraine.
    Freitag FG.
    Expert Rev Neurother; 2007 May; 7(5):463-70. PubMed ID: 17492897
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A in prophylactic treatment of migraine.
    Anand KS, Prasad A, Singh MM, Sharma S, Bala K.
    Am J Ther; 2006 May; 13(3):183-7. PubMed ID: 16772757
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin in migraine prophylaxis.
    Göbel H.
    J Neurol; 2004 Feb; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [Abstract] [Full Text] [Related]

  • 13. [Prophylaxis of chronic daily headache with a simplified regimen of subcutaneous administration of botulinum toxin type A].
    Martín-Araguz A, Garrido-Carrión A, Fernández-Armayor V.
    Rev Neurol; 2004 Feb; 45(7):385-8. PubMed ID: 17918102
    [Abstract] [Full Text] [Related]

  • 14. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG, Diamond S, Diamond M, Urban G.
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J.
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 17. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
    von Lindern JJ.
    Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
    [Abstract] [Full Text] [Related]

  • 18. BOTOX for headache treatment.
    Rothrock JF.
    Headache; 2007 Feb; 47(2):345-6. PubMed ID: 17300388
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM, Schim JD, Chippendale TJ.
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [Abstract] [Full Text] [Related]

  • 20. ["Headache World 2000". The most recent therapy strategies in headache].
    Straube A.
    MMW Fortschr Med; 2000 Sep 28; 142(39):42-3. PubMed ID: 11072697
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.